Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001415889-24-024389

Options or other derivatives

  • Chief Financial Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Choi Han Wook Chief Financial Officer 2024-09-30 Grant or award · Employee Stock Option (right to buy) +400,000 400,000 D
Loading xslF345X05/form4-10022024_081024.xml…